Invasive Lobular Breast Cancer, an overlooked Subtype in Clinical Trials was one of the Poster Presentations at ESMO Breast Cancer Conference in Berlin last week. Lobular Ireland are very proud to be co authors on this piece of work led by Karen Van Baelen as Researcher from the European Lobular Breast Cancer Consortium from Leuven.…
The International ILC Symposium 2022 was hosted in Utrecht the Nederlands this week, June 2022. The European Lobular Breast Cancer Consortium http://www.elbcc.org is supported by European Cost Action #CA19138 #Lobsterpot bringing together Scientific Experts from all ILC Breast Cancer disciplines, Clinical, Surgical, Oncology, Pathology, Histopathology, who collaborate and share their knowledge to promote further partnerships…
The City of Utrecht and The European Lobular Breast Cancer Consortium will play host to the 2022 International ELBCC Lobsterpot Lobular Breast Cancer Symposium and Summerschool Full Agenda can be found at this link https://ilcsymposium2022.com/ There will be a two hour Patient Advocate led Session on Tuesday 21st where we look forward to meeting, many…
When I was Diagnosed with Lobular Breast Cancer, 6 years ago there was NO Lobular Specific information available to patients. That is now changed, Lobular Ireland and I are so proud to be a very small part in making this change. Not all #BreastCancer is the same, it’s so important to know this. Signs and…
FOCUS ON LOBULAR BREAST CANCER Front Cover News thanks to Collaborative Research from The European Lobular Breast Cancer Consortium http://www.elbcc.org Congratulations from #ILC Patient Community Invasive lobular carcinoma (ILC) is the most common ‘‘special type’’ breast cancer (BC) worldwide. ILC often has larger tumors on presentation and a unique pattern of metastatic spread compared to…
I just want to highlight some of the ILC Advocacy work that I’ve been involved closely with this year so far as Patient Advocate with http://www.Lobularireland.com and http://www.elbcc.org A real highlight has been our association with the recently published paper How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer As founder member of Lobular Ireland…
Researchers, Clinicians, Patients, Patient Advocates, Scientists – Registration is open for #Lobular2021 For Registration and Program of Events http://ilcsymposium.com/ This year’s ILC Symposium has a stellar program of events for anyone interested in learning more about Lobular Breast Cancer. Register now for the #Lobular2021 Symposium 24th – 25th June Lobular Ireland are delighted to be…
Lobular Ireland 